- Phare
- Validé par KD/KO
Anticorps Recombinant de lapin anti-Beta galactosidase
Beta galactosidase Recombinant Antibody for WB, IF/ICC, FC (Intra), ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
WB, IF/ICC, FC (Intra), ELISA
Conjugaison
Non conjugué
CloneNo.
240788F1
N° de cat : 83706-6-RR
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules A549, cellules HEK-293, cellules HepG2, cellules K-562, cellules SH-SY5Y |
Résultats positifs en IF/ICC | cellules HepG2, |
Résultats positifs en FC (Intra) | cellules A549, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:125-1:500 |
Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Informations sur le produit
83706-6-RR cible Beta galactosidase dans les applications de WB, IF/ICC, FC (Intra), ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Lapin / IgG |
Clonalité | Recombinant |
Type | Anticorps |
Immunogène | Beta galactosidase Protéine recombinante Ag7792 |
Nom complet | galactosidase, beta 1 |
Masse moléculaire calculée | 76 kDa |
Poids moléculaire observé | 62-67 kDa |
Numéro d’acquisition GenBank | BC007493 |
Symbole du gène | GLB1/Beta-galactosidase |
Identification du gène (NCBI) | 2720 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Protein A purfication |
Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
GLB1(Beta-galactosidase) is also named as ELNR1 or Lactase. It cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans. This protein is identical to the elastin-binding protein (EBP), a major component of the nonintegrin cell surface receptor complex expressed in fibroblasts, smooth muscle cells, chondroblasts, leukocytes, and certain cancer cell types. Defects in GLB1 are the cause of GM1-gangliosidosis type 1 (GM1G1), GM1-gangliosidosis type 2 (GM1G2), GM1-gangliosidosis type 3 (GM1G3) and mucopolysaccharidosis type 4B (MPS4B). GBL1 is synthesized as an 85-kDa precursor that is C-terminally processed into a 64-66 kDa mature form and the released ~20-kDa proteolytic fragment was thought to be degraded (PMID: 10744681). The MW of GLB1 after glycosylation is 100-120 kd. GLB1 is prone to produce homodimers (220-240 kd) and higher multimers (PMID: 3926488). GLB1 has 3 isoforms with MW of 76 kDa, 73 kda, and 61 kDa.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for Beta galactosidase antibody 83706-6-RR | Download protocol |
IF protocol for Beta galactosidase antibody 83706-6-RR | Download protocol |
FC protocol for Beta galactosidase antibody 83706-6-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |